Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Tenforde

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
MMWR. Morbidity and Mortality Weekly Report|May 25, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2020
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020Wesley H Self, Mark W Tenforde, William B Stubblefield, et al.
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
CHEST Critical Care|November 28, 2023
Early Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19Michael J Lanspa, Siddharth P Dugar, Heather L Prigmore, et al.
MMWR. Morbidity and Mortality Weekly Report|November 25, 2020
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020Wesley H Self, Mark W Tenforde, William B Stubblefield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2024
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2019Mark W Tenforde, Kameela P Noah, Alissa C O'Halloran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 21, 2023
Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United StatesHeidi M Crane, Robin M Nance, Stephanie A Ruderman, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
MMWR. Morbidity and Mortality Weekly Report|May 25, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2020
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020Wesley H Self, Mark W Tenforde, William B Stubblefield, et al.
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
CHEST Critical Care|November 28, 2023
Early Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19Michael J Lanspa, Siddharth P Dugar, Heather L Prigmore, et al.
MMWR. Morbidity and Mortality Weekly Report|November 25, 2020
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020Wesley H Self, Mark W Tenforde, William B Stubblefield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2024
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2019Mark W Tenforde, Kameela P Noah, Alissa C O'Halloran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 21, 2023
Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United StatesHeidi M Crane, Robin M Nance, Stephanie A Ruderman, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Pageof 14